Wound bed assessment, exudate classification, and moisture-balanced dressing selection — from hydrogel to superabsorbent, matched to tissue type and drainage volume
The TIME framework (Tissue, Infection/Inflammation, Moisture balance, Edge) provides a structured lens for wound bed assessment prior to dressing selection. Accurate exudate characterization — volume, viscosity, color, consistency, and odor — is essential because exudate mismanagement is among the leading causes of delayed healing, periwound skin breakdown, and unnecessary dressing changes.
The TIME framework, first proposed by the International Wound Bed Preparation Advisory Board (Schultz et al., 2003) and refined by subsequent WUWHS consensus documents, structures assessment into four clinically actionable domains:
Tissue: Identify the proportion of necrotic (black/brown eschar), sloughy (yellow, stringy), granulating (red, beefy, moist), and epithelializing (pink, resurfacing) tissue by percentage. Necrotic and sloughy tissue increase exudate production and bacterial bioburden.
Infection/Inflammation: Distinguish colonization from critical colonization and clinical infection using classic signs (erythema, warmth, edema, pain) plus subtle signs in chronic wounds (friable granulation, increased exudate, malodor, delayed healing, wound bed discoloration, pocketing).
Moisture balance: The central axis for dressing selection. Exudate is graded by volume — none/dry (wound bed appears dehydrated), low (dressing barely moist at change), moderate (dressing wet but not saturated, 24–72h wear typical), high/heavy (dressing saturated within hours, strike-through common, periwound maceration risk elevated).
Edge: Non-advancing or undermined edges suggest a stalled healing trajectory requiring further diagnostic workup (biofilm, ischemia, pressure).
Exudate composition varies by etiology: venous leg ulcers typically produce the highest volumes (100–500 mL/day in severe cases) due to venous hypertension and capillary leak of protein-rich fluid; diabetic foot ulcers and pressure injuries usually range low-to-moderate unless infected; surgical dehiscence wounds vary widely. Viscosity and color also carry diagnostic weight: thin, watery, serous fluid is typical of venous disease; thick, opaque, or purulent fluid suggests infection; pink-tinged fluid indicates capillary fragility or trauma; green-tinged malodorous exudate suggests Pseudomonas aeruginosa colonization.
Exudate volume alone should never dictate dressing choice in isolation — periwound skin condition, wound depth, and the presence of undermining or tunneling must be assessed together, since a highly absorptive dressing applied to a shallow, low-exudate wound can desiccate the bed and arrest healing.
George Winter's landmark 1962 porcine study demonstrated that wounds kept moist under an occlusive film re-epithelialized roughly twice as fast as wounds left to dry and form a scab. This finding overturned decades of "let the wound dry out" dogma and established moist wound healing as the foundation of modern dressing science — but moisture must be balanced, not maximized.
Moist wound healing supports three critical processes that desiccated environments impair:
1. Autolytic debridement — endogenous proteolytic enzymes (matrix metalloproteinases, elastase, collagenase) delivered by neutrophils and macrophages require an aqueous environment to liquefy necrotic tissue and fibrin.
2. Cell migration — keratinocytes migrate across the wound surface via a moist interconnected pathway; a dry scab or eschar forces cells to burrow beneath it, delaying resurfacing by days to weeks.
3. Growth factor bioavailability — cytokines and growth factors (PDGF, TGF-β, VEGF) present in wound fluid degrade rapidly when the environment dries, but chronic wound fluid itself becomes counterproductive when present in gross excess, as it is enriched in matrix metalloproteinases that degrade the provisional matrix and growth factors necessary for healing.
Conversely, excess moisture causes maceration: prolonged (typically >72 hours of continuous) contact of exudate with periwound skin leads to a white, wrinkled, softened epidermis with compromised barrier function, expanding the wound margin and increasing infection risk. The clinical target is a moist, glistening wound bed with dry, intact periwound skin — a narrow physiological window that dressing selection is designed to maintain.
EWMA (European Wound Management Association) and WUWHS position documents formalize a stepwise moisture-balance algorithm: match the dressing's fluid-handling capacity to the wound's exudate output, reassess at each dressing change, and step up or down in absorptive capacity as the wound trajectory changes.
Modern wound dressings span a spectrum of fluid-handling capacity, from hydrogels that donate moisture to dry wounds through superabsorbent polymers that can absorb many times their own weight. Selecting the correct category is the single highest-leverage decision in exudate management.
Hydrogel (amorphous gel, sheet, or impregnated gauze): 70–90% water content; donates moisture to dry, sloughy, or necrotic wound beds to rehydrate devitalized tissue and support autolytic debridement. Indicated for none-to-low exudate. Contraindicated in moderate-high exudate wounds, where it can over-hydrate and macerate.
Hydrocolloid (occlusive wafer, gel-forming carboxymethylcellulose/gelatin/pectin matrix): Forms a gel on contact with low-to-moderate exudate, maintains a moist occlusive environment, and is impermeable to bacteria and water. Well suited to granulating and epithelializing wounds with low-moderate drainage. Typical wear time 3–7 days. Malodorous gel on removal is expected, not a sign of infection.
Foam dressing (polyurethane foam, often with a semi-permeable film backing): Vertically wicks fluid away from the wound surface into the foam matrix, reducing lateral spread and periwound maceration. Handles moderate-to-high exudate; some silicone-faced foams allow atraumatic removal. Available with adhesive borders or as island dressings for secondary use.
Alginate (calcium/sodium alginate derived from brown seaweed): Highly absorptive fibrous dressing forming a gel on contact with exudate via ion exchange (calcium for sodium), releasing calcium ions that support local hemostasis. Absorbs 15–20× its own weight; ideal for high-exudate wounds and cavity/tunneling packing. Requires a secondary dressing.
Hydrofiber (sodium carboxymethylcellulose fiber): Similar indications to alginate — high exudate, cavity packing — but forms a cohesive gel that is easier to remove intact and offers superior vertical wicking with less lateral spread, reducing maceration risk in deep or irregular wounds.
Superabsorbent/composite dressings: Multi-layer constructions with a superabsorbent polymer core (similar technology to infant diapers) capable of absorbing and retaining fluid under compression, critical for heavily exuding venous leg ulcers managed with compression bandaging. Capacity often exceeds 30× dry weight.
Selection algorithm in brief: none/dry + necrotic → hydrogel; low-moderate + granulating → hydrocolloid or thin foam; moderate-high + granulating → foam; high + cavity → alginate or hydrofiber packing plus foam secondary; very high (e.g., venous ulcer under compression) → superabsorbent composite.
Correct application technique prevents two of the most common causes of premature dressing failure: undersizing (leading to strike-through and leakage) and inadequate periwound protection (leading to maceration or medical-adhesive-related skin injury, MARSI).
Application sequence: cleanse wound bed with saline or pH-neutral cleanser, pat periwound skin dry, apply a skin barrier film or paste to periwound margins in moderate-high exudate wounds to prevent maceration, pack cavities loosely (never tightly, which impairs capillary perfusion and delays healing) with ribbon-form alginate or hydrofiber leaving a "tail" for retrieval, then apply the appropriate primary dressing sized 2–3cm beyond the wound margin for adhesive-bordered products, and secure with an appropriate secondary dressing (foam island, retention bandage, or film) as needed.
Wear time is dressing- and exudate-dependent, not fixed by calendar convention: hydrocolloids and foams are commonly changed every 3–7 days when exudate is low-moderate and stable; alginates and hydrofibers in high-exudate or infected wounds may require change every 1–3 days initially, extending as drainage decreases. Manufacturers' recommended maximum wear times should never be exceeded regardless of apparent dressing performance, as prolonged wear increases infection risk and can mask deterioration.
Signs mandating an earlier-than-scheduled change: strike-through (visible exudate breaching the outer dressing surface), leakage or odor, patient-reported pain or burning, periwound erythema or maceration, and dressing displacement. Each unscheduled change should trigger reassessment of exudate volume — if two consecutive changes are needed early, step up absorptive capacity to the next dressing category.
Wound healing is dynamic, and dressing selection must be reassessed at every visit against measurable outcomes: wound dimensions, exudate volume trend, tissue composition, and periwound skin integrity. A four-week percent area reduction benchmark is widely used to flag wounds at risk of chronicity.
Serial wound measurement — length × width (or digital planimetry/photography with a reference scale), and depth with a sterile cotton-tipped applicator — establishes a percent area reduction curve. Failure to achieve approximately 40–50% area reduction by four weeks of optimized standard care is a well-validated predictor of non-healing and should trigger reassessment for underlying barriers: unaddressed biofilm, undiagnosed ischemia, uncontrolled edema, or need for advanced therapy referral.
As granulation tissue fills the wound bed and exudate volume declines, dressing category should be stepped down in absorptive capacity to avoid desiccation — for example, transitioning from an alginate/foam combination to a thin hydrocolloid or foam island as the wound flattens and drainage drops to low-moderate. Conversely, an unexpected increase in exudate volume, change in color/odor, or new periwound erythema should prompt reassessment for infection or biofilm before simply escalating absorptive capacity, since dressing changes alone will not resolve an underlying bioburden problem.
Documentation at each visit should capture: wound dimensions, exudate volume/color/consistency, tissue composition percentages, periwound condition, pain score, and dressing type/wear time — enabling trend analysis and timely escalation of care.